Interdisciplinary epidemiologic and economic research needed to support a universal childhood influenza vaccination policy.
Interdisciplinary epidemiologic and economic research needed to support a universal childhood influenza vaccination policy.
复制标题
需要跨学科的流行病学和经济研究来支持全民儿童流感疫苗接种政策。
DOI：
10.1093/epirev/mxj008
复制
发表时间：
2006
影响因子：
5.5
通讯作者：
Prill,MilaM
中科院分区：
文献类型：
--
作者：
Coleman,MargaretS;Washington,MichaelL;Orenstein,WalterA;Gazmararian,JulieA;Prill,MilaM
最近的研究表明，与针对严重疾病高风险人群的疫苗接种相比，儿童流感疫苗接种可能在更大程度上减少成人流感疾病负担。反映这些结果的可能的新政策将在现有的疫苗接种建议中增加最有可能传播疾病的群体。需要将流行病学与经济学相结合的跨学科研究来回答有关潜在新政策的可取性和可行性的关键问题，例如医疗提供者可能需要哪些额外资源来将疫苗接种扩大到更大的群体，或者父母每年为孩子接种疫苗可能会产生哪些机会成本。在本文中，作者提供了流感疫苗接种率和疾病的一些变化的背景，并讨论了现有的信息差距和能够缩小这些差距的研究方法。他们提供了几个跨学科研究的例子，包括经济学和流行病学或卫生政策问题。这些研究代表了各种利益相关者的观点，需要确定以社区为基础的普遍儿童疫苗接种政策是否比针对疾病并发症高风险人群的战略更有效和更具成本效益。
Recent research indicates that influenza vaccination of children may decrease the influenza disease burden in adults to a greater extent than targeting vaccination to populations at high risk of serious disease. Possible new policies reflecting these results would add groups most likely to transmit disease to existing vaccination recommendations. Interdisciplinary research combining epidemiology with economics is needed to answer critical questions about the desirability and feasibility of potential new policies, such as what additional resources medical providers might need to expand vaccination to larger groups or what opportunity costs parents might incur in vaccinating their children annually. In this paper, the authors provide background for some of the changes in influenza vaccination rates and disease and discuss existing information gaps and research methods capable of closing these gaps. They provide several examples of interdisciplinary studies that have incorporated both economics and epidemiology or health policy issues. These studies are representative of a variety of stakeholder perspectives needed to determine whether community-based, universal childhood vaccination policies would be more efficacious and cost-effective than strategies targeted toward persons at high risk of disease complications.